Paper27282
Which drug for hypertension?
Br Med J, 1978. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Which drug for hypertension? Papers, record 27282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27282
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension | Major topic |
| Adrenergic beta-Antagonists | |
| Benzothiadiazines | |
| Diuretics | |
| Humans | |
| Methods | |
| Renin | |
| Sodium Chloride Symporter Inhibitors |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,124,993 | Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension. | Lancet | 1973 | https://conductscience.org/library/papers/4124993 | PubMed |
| 2 | 4,757,789 | Are patients with essential hypertension and low renin protected against stroke and heart attack? | Am Heart J | 1973 | https://conductscience.org/library/papers/4757789 | PubMed |
| 3 | 74,494 | Coronary heart-disease after treatment of hypertension. | Lancet | 1978 | https://conductscience.org/library/papers/74494 | PubMed |
| 4 | 5,337,088 | Why do thiazide diuretics lower blood pressure in essential hypertension? | Annu Rev Pharmacol | 1967 | https://conductscience.org/library/papers/5337088 | PubMed |
| 5 | 5,437,415 | Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. | Circulation | 1970 | https://conductscience.org/library/papers/5437415 | PubMed |
| 6 | 55,840 | Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment. | Lancet | 1976 | https://conductscience.org/library/papers/55840 | PubMed |
| 7 | 62,162 | Low renin hypertension. A distinct entity. | Lancet | 1976 | https://conductscience.org/library/papers/62162 | PubMed |
| 8 | 1,172,683 | The prognostic implications of plasma renin in essential hypertension. | JAMA | 1975 | https://conductscience.org/library/papers/1172683 | PubMed |
| 9 | 47,997 | Total body and serum potassium during prolonged thiazide therapy for essential hypertension. | Lancet | 1975 | https://conductscience.org/library/papers/47997 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 3,884,320 | Diuretics. Clinical pharmacology and therapeutic use (Part II). | Drugs | 1985 | https://conductscience.org/library/papers/3884320 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27282
GET https://conductscience.org/api/papers/v1/27282/authors